Long-term consumption of an amino acid diet reduces the pancreatic enzyme secretion response to a trypsin inhibitor in rats.
We investigated pancreatic enzyme secretion in response to soybean trypsin inhibitor (SBTI) in rats fed amino acids as a nitrogen source, from the fetal stage to adulthood. Pregnant rats were divided into two groups 4 d before parturition. During gestation and nursing, one group was fed a 15% protein diet (protein-fed rats) and the other (amino acid-fed rats) a 15% amino acid mixture diet that simulated the composition of the protein diet. Each male offspring was weaned at 4 wk after parturition and fed the same diet as fed to its dam for an additional 6 wk. Pancreatic amylase secretion in response to an intraduodenal infusion of SBTI (10 mg/rat) was observed in the protein-fed rats but not in the amino acid-fed rats. Amylase secretion in response to an intravenous injection of cholecystokinin (CCK) (10 ng/kg rat) was observed in both groups, and the magnitude of the response was significantly higher in the amino acid-fed rats than in the protein-fed rats. An increase in the level of plasma CCK in response to SBTI was observed in the protein-fed rats but not in the amino acid-fed rats. These results suggest that the long-term amino acid diet, because of its ability to inhibit the SBTI-stimulated CCK-releasing process in the small intestine of rats, reduced the pancreatic enzyme secretion response to a trypsin inhibitor. Six rats fed the amino acid mixture until 1 wk after weaning were fed the protein diet for the next 5 wk. These rats showed no pancreatic amylase secretion in response to SBTI, suggesting that dietary components around the weaning stage may affect the development of the ability of small intestinal cells to recognize a trypsin inhibitor.
Miura
Y
Y
Department of Food Science and Technology, Faculty of Agriculture, Kyoto University, Kyoto 606-01, Japan.
Murayama
H
H
Tsuzuki
S
S
Sugimoto
E
E
Torii
K
K
Fushiki
T
T
D000596:Amino Acids / Q000008:administration & dosage / Q000494:pharmacology*; D000681:Amylases / Q000032:analysis / Q000378:metabolism*; D000818:Animals; D001835:Body Weight / Q000187:drug effects / Q000502:physiology; D002766:Cholecystokinin / Q000097:blood / Q000494:pharmacology; D004044:Dietary Proteins / Q000008:administration & dosage / Q000494:pharmacology*; D004527:Egg Proteins / Q000494:pharmacology; D005260:Female; D007668:Kidney / Q000033:anatomy & histology; D008099:Liver / Q000033:anatomy & histology; D008297:Male; D018377:Neurotransmitter Agents / Q000097:blood / Q000494:pharmacology; D009929:Organ Size / Q000187:drug effects / Q000502:physiology; D010179:Pancreas / Q000033:anatomy & histology / Q000201:enzymology* / Q000378:metabolism; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar; D013154:Spleen / Q000033:anatomy & histology; D013997:Time Factors; D014361:Trypsin Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*
D000596:Amino Acids; D004044:Dietary Proteins; D004527:Egg Proteins; D018377:Neurotransmitter Agents; D014361:Trypsin Inhibitors; D002766:Cholecystokinin; D000681:Amylases